[go: up one dir, main page]

UY28662A1 - Agente endoparasiticida para administracion topica - Google Patents

Agente endoparasiticida para administracion topica

Info

Publication number
UY28662A1
UY28662A1 UY28662A UY28662A UY28662A1 UY 28662 A1 UY28662 A1 UY 28662A1 UY 28662 A UY28662 A UY 28662A UY 28662 A UY28662 A UY 28662A UY 28662 A1 UY28662 A1 UY 28662A1
Authority
UY
Uruguay
Prior art keywords
endoparasiticide
agent
topical administration
depsypeptides
praziquantel
Prior art date
Application number
UY28662A
Other languages
English (en)
Inventor
Dr Venkata-Rangarao Kanikanti
Dr Thomas Bach
Dr Gertraut Altreuther
Dr Michael Traubel
Dr Hans-Jurgen Hamnn
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of UY28662A1 publication Critical patent/UY28662A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a agentes de administración transdérmica que contienen depsipéptidos cíclicos y/o prazicuantel, así como a su preparación y uso para combatir endoparásitos.
UY28662A 2003-12-13 2004-12-09 Agente endoparasiticida para administracion topica UY28662A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation

Publications (1)

Publication Number Publication Date
UY28662A1 true UY28662A1 (es) 2005-07-29

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28662A UY28662A1 (es) 2003-12-13 2004-12-09 Agente endoparasiticida para administracion topica

Country Status (31)

Country Link
US (1) US7763583B2 (es)
EP (1) EP1694291B1 (es)
JP (1) JP4842141B2 (es)
KR (1) KR101272139B1 (es)
CN (1) CN1893919B (es)
AR (1) AR046878A1 (es)
AT (1) ATE447940T1 (es)
AU (1) AU2004296537B2 (es)
BR (1) BRPI0417578B1 (es)
CA (1) CA2548897C (es)
CR (1) CR8428A (es)
DE (2) DE10358525A1 (es)
DK (1) DK1694291T3 (es)
ES (1) ES2334920T3 (es)
GT (1) GT200400264A (es)
HR (1) HRP20100056T1 (es)
IL (1) IL176151A (es)
MX (1) MXPA06006594A (es)
MY (1) MY142044A (es)
NO (1) NO20063171L (es)
NZ (1) NZ547837A (es)
PE (1) PE20050919A1 (es)
PL (1) PL1694291T3 (es)
PT (1) PT1694291E (es)
RU (1) RU2401108C2 (es)
SI (1) SI1694291T1 (es)
TW (1) TWI341202B (es)
UA (1) UA85574C2 (es)
UY (1) UY28662A1 (es)
WO (1) WO2005055973A2 (es)
ZA (1) ZA200604744B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
EP2040731A4 (en) * 2006-06-09 2010-05-19 Merrion Res Iii Ltd SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
US20090280169A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
TWI480286B (zh) * 2009-02-25 2015-04-11 Merrion Res Iii Ltd 雙膦酸鹽類組合物及藥物遞送
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
UA115232C2 (uk) * 2011-12-21 2017-10-10 Байєр Інтеллектуал Проперті Гмбх Препарат, що містить аморфний емодепсид
CA2895038C (en) * 2012-12-18 2020-11-24 Donaghys Limited Transdermal parasiticidal formulations
EP3104940B1 (en) * 2014-02-14 2021-10-06 DSM IP Assets B.V. Arachidonic acid and praziquantel for the prevention and/or treatment of schistosomiasis
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
US10081656B2 (en) 2015-05-20 2018-09-25 Merial, Inc. Anthelmintic depsipeptide compounds
HUE065907T2 (hu) 2015-12-28 2024-06-28 Boehringer Ingelheim Vetmedica Gmbh Anthelmintikus hatású depszipeptid vegyületek
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
MY203299A (en) 2017-11-07 2024-06-21 The Kitasato Inst Method for the synthesis of cyclic depsipeptides
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
CN1384832A (zh) * 1999-11-18 2002-12-11 诺瓦提斯公司 作为农药的氨基杂环基酰胺化合物
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ATE320812T1 (de) 2000-10-10 2006-04-15 Wyeth Corp Anthelmintika
WO2002049641A2 (en) * 2000-12-20 2002-06-27 Novartis Ag Anti-endoparasitic amidoacetonitrils
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
AU2004228041B2 (en) * 2003-04-04 2009-06-04 Boehringer Ingelheim Animal Health USA Inc. Topical anthelmintic veterinary formulations

Also Published As

Publication number Publication date
BRPI0417578B1 (pt) 2015-12-22
MXPA06006594A (es) 2006-08-23
NO20063171L (no) 2006-07-07
IL176151A0 (en) 2006-10-05
GT200400264A (es) 2005-08-18
SI1694291T1 (sl) 2010-03-31
HRP20100056T1 (hr) 2010-03-31
TWI341202B (en) 2011-05-01
CA2548897C (en) 2012-04-10
TW200533384A (en) 2005-10-16
UA85574C2 (uk) 2009-02-10
CN1893919B (zh) 2010-09-29
EP1694291B1 (de) 2009-11-11
WO2005055973A3 (de) 2005-08-11
PL1694291T3 (pl) 2010-04-30
CR8428A (es) 2006-11-23
JP2007513903A (ja) 2007-05-31
IL176151A (en) 2013-12-31
AU2004296537A1 (en) 2005-06-23
NZ547837A (en) 2010-02-26
PT1694291E (pt) 2010-01-18
JP4842141B2 (ja) 2011-12-21
EP1694291A2 (de) 2006-08-30
ZA200604744B (en) 2007-09-26
ES2334920T3 (es) 2010-03-17
US20070060509A1 (en) 2007-03-15
ATE447940T1 (de) 2009-11-15
RU2006124964A (ru) 2008-01-20
RU2401108C2 (ru) 2010-10-10
PE20050919A1 (es) 2005-12-16
AR046878A1 (es) 2005-12-28
CN1893919A (zh) 2007-01-10
DE502004010367D1 (de) 2009-12-24
BRPI0417578A (pt) 2007-03-20
DK1694291T3 (da) 2010-03-15
WO2005055973A2 (de) 2005-06-23
DE10358525A1 (de) 2005-07-07
CA2548897A1 (en) 2005-06-23
MY142044A (en) 2010-08-30
KR101272139B1 (ko) 2013-06-10
KR20060103953A (ko) 2006-10-04
HK1102915A1 (en) 2007-12-07
AU2004296537B2 (en) 2010-05-13
US7763583B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
UY28662A1 (es) Agente endoparasiticida para administracion topica
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
UY29086A1 (es) Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos.
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
CL2007002635A1 (es) Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion.
NO20080068L (no) Topisk unguale formuleringer
ECSP10010548A (es) Composiciones y metodos de preparacion y uso de las mismas
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CL2011001392A1 (es) Compuestos derivados de pteridinona, moduladores de receptores tipo toll; composicion farmaceutica que lo comprende, util en el tratamiento de una infeccion viral, cancer, asma, entre otras.
UY31080A1 (es) Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
CR20110163A (es) Uso de ditiina-tetracarboxamidas para combatir hongos fitopatógenos
CR9786A (es) Compuestos de bencimidazol-tiofeno
UY31079A1 (es) Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
CR10305A (es) "derivados sustituidos de cromanol y su uso.
CR9364A (es) Agentes endoparasiticidas
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
CR9108A (es) Prevencion de infecciones endoparasitas verticales
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
BRPI0510938A (pt) vitamina k1 como energizador em formulações cosméticas
BRPI0511389A (pt) composição e seu uso
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
BRPI0516663A (pt) bengamidas que possuem um ciclocaprolactama substituìdo, processo de preparo, composições que os contém e a utilização
BR0009194A (pt) Composição do resorcinol
BRPI0518554A2 (pt) uso de um inibidor de pde3

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150608